CD56brightCD16dim NK cells expressing KIR3DL1/DL2 were significantly increased in controls and moderate CFS/ME patients after 6 months (p < 0.000 and 0.004) (Fig. 4a). This evidence concerns the gene KIR3DL1 and myalgic encephalomeyelitis/chronic fatigue syndrome.